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Pulmonary Neuroendocrine Cells in Neonatal Rats With Congenital 
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Rotterdam, The Netherlands and Toronto, Ontario 
• Lung hypoplasia and persistent pulmonary hypertension 
are the principal causes of high mortality and morbidity in 
infants with congenital diaphragmatic hernia (CDH}. Amine- 
and peptide-producing pulmonary neuroendocrine cells 
(PNEC), widely distributed throughout the airway mucosa, 
are thought to play an important role in both pulmonary 
development and regulation of pulmonary vascular tone. 
Furthermore, recent studies show increased levels of calcito- 
nin gene-related peptide (CGRP), a pulmonary vasodilator 
produced by PNEC, during chronic hypoxia. The article 
reports data on morphometric analysis of CGRP immunoreac- 
tire PNEC clusters (neuroepithelial bodies, NEB) in a rat 
model of CDH. CDH was induced in neonatal Sprague Dawley 
rats by oral administration of 2,4-dichloro-phenyl-p-nitro- 
phenylether (Nitrofen; Rohm Haas, Philadelphia, PA) to the 
mother at 10 days of gestation. Sections of lungs from term 
neonatal rats with and without CDH and controls were 
immunostained for CGRP {marker of NEB) with specific 
antibody against rat CGRP. NEB size and number of NEB/ 
area of lung were assessed using a semiautomatic image 
analysis system. In lungs of neonatal rats with CDH, the 
number of NEB per surface area of lung parenchyma was 
significantly increased compared with the age-matched con- 
trois. Although the mean size of NEB was larger in CDH, the 
differences were not significant. This is the first study of 
PNEC in CDH. Whether the phenomenon observed in this 
study results in altered NEB function including imbalance in 
vasoactive mediators requires further studies, especially in 
the human being. 
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C ONGENITAL diaphragmatic hernia (CDH) is a serious malformation with a high mortality and 
morbidity caused by pulmonary hypoplasia and pulmo- 
nary hypertension. >3 The mortality rate of 40% to 
50% has not changed during the past few years 
despite changing concepts in treatment, including 
delayed surgery and extracorporeal membrane oxygen- 
ation (ECMO). 4 Factors that may contribute to pul- 
monary hypertension i general as well as in CDH 
have been studied intensively. Pulmonary neuroendo- 
crine cells (PNEC), a known source of a variety of 
biological active compounds, have only been studied 
recently. These amine- and peptide-producing cells 
are widely distributed throughout the airway mucosa 
and are found as solitary cells or as clusters that are 
called neuroepithelial bodies (NEB). s PNEC are 
thought to play an important role during lung develop- 
ment s,6 and neonatal adaptation, s,7particularly in the 
regulation of pulmonary vascular tone. 8One of the 
peptides produced by PNEC is calcitonin gene- 
related peptide (CGRP). In human beings, CGRP 
immunoreactive c lls are found from 22 weeks of 
gestation 9 mostly within the epithelium of distal 
conducting airways and in nerves around blood ves- 
sels. 1° Both in rats and in humans CGRP is known to 
show a potent vasodilatory sJ°,n and a bronchocon- 
stricting activity. Recent studies showed increased 
levels of intracellular CGRP in chronically hypoxic 
rats 12 and in lungs of children with bronchopulmo- 
nary dysplasia. 13Because PNEC were not previously 
studied in CDH, we investigated the distribution and 
frequency of CGRP immunoreactive PNEC in a rat 
model of CDH and pulmonary hypoplasia. TM The aim 
of this study was to determine whether these cells and 
their mediators may play a role in problems associ- 
ated with CDH in newborns. 
MATERIALS  AND METHODS 
Female Sprague-Dawley rats (Harlan Olac, England) were 
mated overnight (day 0 of gestation). To induce CDH, a subgroup 
of pregnant rats received orally 100 mg of 2,4-dichloro-phenyl-p- 
nitrophenylether (Nitrofen; Rohm and Haas, Philadelphia, PA), 
dissolved in 1 rnL of olive oil, on day 10 of gestation. Nitrofen 
administration i duces a left-sided or bilateral diaphragmatic 
defect in 70% to 90% of the offspring using this protocol. The 
offsprings of the rats without Nitrofen administration served as 
normal controls. Food and water were supplied ad libitum during 
the whole period of pregnancy. At gestational day 22 (term) the 
mother was anesthesized by inhalation of ether and a cesarean 
section was performed. The fetuses were removed and killed 
before any breathing occurred. The presence of a diaphragmatic 
defect was assessed and the lungs, with trachea attached, were 
removed for histological examination. Three study groups were 
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included: normal controls (n = 7), rats that developed CDH 
(n = 9) and rats without CDH (non-CDH) (n = 3) in the Nitrofen 
group. 
The lungs were fixed by immersion in Davidson's olution (40 
vol% ethanol 100%, 5 vol% acetic acid 96%, I0 vol% formalde- 
hyde 37%, 45 vol% saline; pH 7.3) and embedded in paraffin. 
Immunostaining for CGRP was performed with specific rabbit 
polyclonal antibody against rat CGRP (CA-08-220, Cambridge 
Research Biochemicals, Wilmington, DE) using a well-established 
protocol, as, 16 
Morphometric analysis including measurements of NEB size, 
number of NEB per section, surface area of lung sections, and 
frequency of NEB (the number of NEB per mm 2 of lung) were 
performed using Apple Macintosh National Institutes of Health 
(NIH) Image 1.49 programme. 
All values were expressed as mean _ SEM. Group means were 
compared using the Student's t test, and significance was accepted 
at 5% level. 
RESULTS 
All rats except wo in the CDH group had major 
left-sided or bilateral diaphragmatic defects. Two 
animals with a small right-sided efect were not 
included in further analysis. In all groups a positive 
immunostaining for CGRP was detected. More promi- 
nent and numerous NEBs were found in the lungs of 
CDH rats (Fig 1A) compared with normal controls 
(Fig 1B). 
The findings of the morphometric analysis are 
summarized in Table 1. The pulmonary area in rats 
exposed to Nitrofen was significantly smaller com- 
pared with that of controls (P < .001), and in CDH it 
was significantly smaller than in non-CDH rats 
(P < .01). The number of NEB per mm 2 of lung area 
in rats with CDH was significantly greater compared 
with that of both other groups (P < .01 compared 
with controls, P < .05 compared with non-CDH). 
Furthermore, the mean size of NEB was greater in 
CDH rats, but this was not statistically significant. 
DISCUSSION 
Our findings suggest hat in rats with CDH and 
pulmonary hypoplasia there is a proportionally higher 
number of NEB immunostained forCGRP. Nitrofen- 
exposed animals without CDH had a smaller lung 
area compared with normal controls. However, the 
relative frequency of NEB per mm 2 of lung was 
comparable tothe frequency of NEB seen in controls. 
This suggests hat in CDH there may be an additional 
factor apart from the pulmonary hypoplasia with a 
resulting delayed maturation oflung parenchyma. 
With respect to the role of PNEC in lung develop- 
ment, different hypotheses are put forward. Cutz et 
al 6 showed that in the developing human lung the 
differentiation of PNEC proceeds in a craniocaudal 
Fig 1, (A) Prominent NI=Bs (arrows) in the airways of a CDH rat 
immunostained for CGRP and counterstained with haematoxylin. 
x125; pa, pulmonary artery. (B) Fewer NEBs (arrows) are seen in the 
airways of a normal control rat, Immunostaining as in Fig 1A. (Original 
magnification x 125). 
direction with more prominent serotonin-immunore- 
active cells during the early stages. In contrast, 
bombesin-immunoreactive ells reach their maximum 
number at birth. Spindel et al av found that levels of 
GRP, the mammalian homologue of bombesin, in- 
crease during gestation and remain elevated until 
several months after birth, whereas GRP mRNAs 
reach their maximum levels from 16 to 30 weeks of 
gestation and then decline by 34 weeks of gestation. 
Wada et al 7 studied the developmental changes in the 
Table 1. Morphometric Analysis of Lungs of Neonatal Rats With CDH 
Immunostained for CGRP 
CDH (n = 7) Non-CDH (n = 3) Control (n = 7) 
NEB size (p.m) 843.1 -+ 67.6 767.7 + 94.2 737.5 +- 40.9 
Number of NEB 20.9 -+ 2.2 16.3 -+ 1.2" 30 -+ 4.3 
Area of lung (ram 2) 22.2 -+ 1.1"t 29.8 -+ 3.8* 51.4 -+ 1.2 
Number of NEB per 
mm 2 lung 0,95 -+ 0.11"1" 0.52 _+ 0.04 0.58 -+ 0.07 
*Significantly different f rom control. 
tSignif icantly different f rom non-CDH. 
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expression of the CGRP gene in rat lungs. CGRP- 
positive cells did not appear in lung tissue before the 
18th day of gestation and declined within 1 week after 
birth. These studies uggest involvement of PNEC in 
normal lung development and a possible role for 
CGRP in pulmonary adaptation from late intrauter- 
ine stages to the early neonatal period. 
Earlier studies from our group in rats showed that 
morphologically hypoplastic lungs are less mature 
near term. 18 It can be assumed that in CDH the 
immaturity ofthe lungs is also reflected in the number 
of NEB. The findings of Wada et al 7 do not support 
this assumption. Further studies are required to show 
whether our findings reflect immaturity ofthe lung in 
CDH or reflect hat a new characteristic of the lung in 
CDH has now been discovered. 
Stahlman et al t9 performed a study of colocaliza- 
tion of peptide hormones in PNEC of human fetuses 
and newborns. They showed that in normal fetuses 
the percentage of granules labeled for CGRP was 
consistently ower compared with abnormal fetuses 
and children dying from pulmonary disease. This 
percentage increased with the severity of pathological 
changes, being highest in hyaline membrane disease 
and bronchopulmonary dysplasia. 
Springall et a112,16 described an increase in intracel- 
lular levels of CGRP in PNEC of hypoxic rats. This 
could have important implications inthe vasoconstric- 
tor response to hypoxia. Furthermore, Youngson et 
al 2° showed that NEB are transducers of the hypoxic 
stimulus and therefore may function as airway chemo- 
receptors in the regulation of respiration. In our 
experiment the neonatal rats were killed immediately 
after a cesarean section before severe hypoxia after 
birth could occur. The adaptation from intrauterine 
to extrauterine life is unlikely to explain our findings 
for the same reason. A process already existing in 
utero may result in the higher number of NEB seen in 
CDH. The immunoreactivity of PNEC in CDH in 
humans is presently being investigated. 
Whether an altered NEB function, including imbal- 
ance in vasoactive mediators, is involved in the 
continuing high mortality and morbidity of CDH is 
still unclear. Further studies in rats and in humans 
with other mediators such as serotonin are now being 
performed in our department. 
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